Minimising the immunogenicity of biopharmaceuticals: Current status of monitoring immunogenicity across the R&D value chain

At the 2014 Exploratory Clinical Development World Europe, Sylvia Julien, Principal Scientist, Senior Project Leader Global Scientific Affairs and Strategic Sourcing, Ipsen,  gave a presentation on “Minimising the immunogenicity of biopharmaceuticals: Current status of monitoring immunogenicity across the R&D value chain. Download and learn: Immunogenicity and influencing factors Immunogenicity risk assessment, stage-based Conclusion and perspectives Download Presentation. Found this interesting? Join us …

Download Whitepaper: Security of supply for Chromatography Media

  Manufacturing of biopharmaceuticals is a large commitment to the public health and helps save the lives of millions of people. The complex nature of biopharmaceuticals makes manufacturing a challenge, in which a consistent, high-quality end product is dependent of the use of equally consistent, high-quality key manufacturing components. Key manufacturing components are often single-sourced. As it many times is costly …